FDA Approves CAR-T Therapy Tisagenlecleucel for B-Cell Acute Lymphoblastic Leukemia – Cancer Therapy Advisor
Cancer Therapy Advisor |
FDA Approves CAR–T Therapy Tisagenlecleucel for B-Cell Acute Lymphoblastic Leukemia
Cancer Therapy Advisor This approval marks the first chimeric antigen receptor T cell (CAR-T) therapy, which utilizes the patients’ own genetically-modified T–cells to target the CD19 antigen on the surface of leukemia cells. Once modified, the cells are injected back into … |
Cancer Therapy Advisor |
FDA Approves CAR–T Therapy Tisagenlecleucel for B-Cell Acute Lymphoblastic Leukemia
Cancer Therapy Advisor This approval marks the first chimeric antigen receptor T cell (CAR-T) therapy, which utilizes the patients’ own genetically-modified T–cells to target the CD19 antigen on the surface of leukemia cells. Once modified, the cells are injected back into … |
|
FDA approves revolutionary new cell-modifying cancer treatment
The Week Magazine On Wednesday, the Food and Drug Administration approved a revolutionary new type of cancer treatment that genetically modifies the body’s own cells. The treatment, known as CAR–T therapy, is the first type of gene therapy approved in the U.S and will … |
MedPage Today |
FDA Approves CAR T-Cell Therapy for Leukemia
MedPage Today WASHINGTON — The FDA on Wednesday approved a chimeric antigen receptor (CAR) T-cell therapy for treatment of certain pediatric and young adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Calling it a “historic … First CAR T-Cell ‘Living Drug’ Approved by FDAMedscape FDA clears first gene-altering therapy — ‘a living drug’ — for childhood leukemiaWashington Post FDA Approves First Gene Therapy For LeukemiaNPR OncLive –The Scientist –FDA.gov –National Cancer Institute all 656 news articles » |
NPR |
FDA Approves First Cell-Based Gene Therapy For Cancer
NPR The Food and Drug Administration on Wednesday announced what the agency calls a “historic action” — the first approval of a cell-based gene therapy in the United States. The FDA approved Kymriah, which scientists refer to as a “living drug” because it … FDA approval brings first gene therapy to the United StatesFDA.gov The FDA Has Approved the First Gene Therapy for CancerMIT Technology Review FDA announces first US gene therapy approval for cancer treatmentCNN PBS NewsHour –CBS News –Science Magazine –Novartis all 98 news articles » |
Medscape |
First CAR T-Cell ‘Living Drug’ Approved by FDA
Medscape The first T–cell therapy that uses chimeric antigen receptor (CAR) technology has been approved today by the US Food and Drug Administration (FDA), paving the way for the other products using this novel approach that are in development. “We’re entering … FDA approval brings first gene therapy to the United StatesFDA.gov Novartis receives first ever FDA approval for a CAR–T cell therapy, Kymriah(TM) (CTL019), for children and young …GlobeNewswire (press release) A cancer treatment that one expert called the ‘most exciting thing I’ve seen in my lifetime’ just got approvedMarkets Insider Chicago Tribune –AJMC.com Managed Markets Network –OncLive all 51 news articles » |
|
US clears breakthrough gene therapy for childhood leukemia
Press of Atlantic City The Food and Drug Administration called the approval historic, the first gene therapy to hit the U.S. market. Made from scratch for every patient, it’s one of a wave of “living drugs” under development to fight additional blood cancers and other tumors … |